Trial Profile
A prospective trial to assess the intra-patient variability of conversion from the twice-daily tacrolimus formulation to a once-daily formulation administered in patients after kidney transplantation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Feb 2016
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Pharmacokinetics
- 10 Feb 2016 New trial record